Gynecologic cancers affect the female reproductive system, including the cervix, ovaries, uterus, vagina, and vulva. While less common than breast cancer, these cancers have higher mortality rates due to limited awareness and lack of early screening options.
According to the National Cancer Institute, over 100,000 women in the United States are diagnosed with gynecologic cancers each year. More than 32,000 deaths are expected annually. Uterine cancer is the most prevalent type with about 65,000 cases per year. Ovarian cancer follows with 20,000 cases annually. Cervical cancer affects between 10,000 and 12,000 new patients each year. Vaginal and vulvar cancers combined account for around 10,000 new cases yearly.
Detecting these cancers can be difficult because there are no established early screening methods and symptoms often appear late or go unnoticed due to low awareness. Symptoms vary by cancer type but may include unusual bleeding for uterine cancer; pelvic pain and abdominal changes for ovarian cancer; vaginal bleeding or discharge for cervical and vaginal cancers; and painful lesions for vulvar cancer.
Hereditary mutations play a significant role in some gynecologic cancers. For example, mutations in BRCA1 and BRCA2 genes increase the risk of ovarian cancer significantly. Genetic testing through a blood draw can help identify individuals at higher risk by detecting such mutations.
Other types of gynecologic cancers—specifically cervical, vulvar, and vaginal—are mainly linked to human papillomavirus (HPV) infection rather than genetic factors. The HPV vaccine helps prevent infections that could lead to these cancers. Routine pap smears remain an important tool for prevention and early detection.
Treatment approaches depend on the specific type of gynecologic cancer but often begin with surgery aimed at removing tumors. Additional therapies like chemotherapy or radiation may follow:
“Cervical cancer: Patients receive surgery followed by radiation therapy. Chemotherapy is also sometimes used for advanced cases.”
“Ovarian cancer: Patients receive surgery and chemotherapy, most often followed by PARP therapy to prevent ovarian cancer from recurring.”
“Uterine cancer: Most uterine cancers can be cured with surgery alone, though radiation or chemotherapy may also be used to ensure the best outcome.”
“Vaginal and vulvar cancer: Patients receive surgery and radiation therapy, with a follow-up of chemotherapy if necessary for late-stage cancers.”
Clinical trials offer some patients access to experimental treatments under medical supervision.
Recent advances in research have improved outcomes for those diagnosed with gynecologic cancers. Early-stage uterine, cervical, and ovarian cancers now have high cure rates; even advanced cases can sometimes be cured completely.
Awareness remains crucial alongside research progress. Patients are encouraged to monitor their health closely: “Patients are encouraged to pay attention to their bodies, trust their instincts when something is wrong, and be their own advocate when seeking a diagnosis and treatment.” If symptoms arise or concerns persist about gynecological health—including issues unrelated to cancer—consultation with a specialist or primary care physician is recommended.
Richmond University Medical Center’s Obstetrics and Gynecology department provides services throughout Staten Island. Those seeking more information about gynecologic cancers or wishing to schedule an appointment can contact them at 718-818-3287.
